Technavio, a tech-focused market research firm, has published a new report on the global interventional oncology market, which is expected to grow at a CAGR of more than 11% during the forecast period, 2017-2021.
Based on geographical segmentation, Technavio’s market researchers categorize the global interventional oncology market into the following key regions: the Americas, APAC, and EMEA.
Source: Technavio
Top three contributors for the global interventional oncology market are elaborated below:
Interventional oncology market in Americas: The growing adoption of MI procedures in the region is the key driving force behind the growth of the interventional oncology market in the Americas. Factors such as advances in technology (equipment, functionalities, and operation) and a highly-established healthcare infrastructure are anticipated to reflect positively on the market’s growth between 2017 and 2021.
According to Barath Palada, a lead analyst at Technavio, specializing in research on orthopedics and general medical devices, “Advances in medical technology have resulted in an increase in the demand for MI techniques as the surgeries as well as post-surgery recoveries are quick. Besides, several new products for interventional oncology procedures are expected to be approved in the Americas during the forecast period, which will increase the value of the market.”
Interventional oncology market in EMEA: The market in EMEA is dominated by Western Europe, as the incidence of cancer is high in Denmark, Belgium, France, and Norway. Advances in technology and the growing older adult population contribute to the growth of the market. The UK, France, Germany, Spain, and Italy with their higher population ratios are significant contributors to the growth of the market.
Interventional oncology market in APAC: The increase in the incidence of cancer cases in the region is projected to propel growth of the interventional oncology market in APAC during the forecast period. Countries such as China, South Korea, and India are potential emerging markets with an increase in the development of healthcare infrastructures, a large aging population, a high incidence of cancer cases, and a rise in general awareness about healthcare.
The top vendors operating in the global interventional oncology market are:
- BTG
- Boston Scientific
- Medtronic
- Merit Medical
- TERUMO CORPORATION
Other prominent vendors in the market include Accuray, ALPINION MEDICAL SYSTEMS, AngioDynamics, AtriCure, Baylis Medical, BOVIE MEDICAL, Brainlab, BSD Medical Corporation, C. R. Bard, C2 Therapeutics, CardioFocus, Cook Medical, Eckert and Ziegler BEBIG, EDAP TMS, Elekta, Galil Medical, HealthTronics, INSIGHTEC, MedWaves, Mermaid Medical, Microsulis Medical, Monteris Medical, NeuWave Medical, Perseon, Profound Medical, Sirtex , Smith & Nephew, SonaCare Medical, and Varian Medical.
A more detailed analysis is available in the Technavio report titled, ‘Global Interventional Oncology Market 2017-2021’.
Other related reports:
- Global Cancer Monoclonal Antibodies Market 2017-2021
- Global Cervical Cancer Diagnostic Testing Market 2016-2020
- Global Cancer Diagnostic Devices Market 2016-2020
To read more press releases – click here
